Similarly, HSP90 inhibitors substantially reduced phosphorylated-KIT and total KIT expression with decreased cell survival observed in KIT-positive GIST (Bauer et al, 2006). The gene discussed is KIT; the disease is gastrointestinal stromal tumor.